QT Vascular gets FDA nod for balloon catheter

Fri, Jun 06, 2014 - 6:00 AM

MEDICAL device provider QT Vascular announced yesterday that its wholly owned subsidiary TriReme Medical has received the approval of the US Food and Drug Administration (FDA) to market its Chocolate PTCA Balloon Catheter in the US.

This device, used in patients with coronary arterial

QT Vascular

Breaking News

10:55 am

Najib back for questioning at Malaysia's anti-graft agency over 1MDB

10:36 am

Uber trims losses and grows business, plans new stock sale

10:27 am

Three shophouses at Liang Seah Street up for sale at S$30m

10:14 am

South Korea: Stocks edge down, won flat; BOK holds rate as expected

10:11 am

Hong Kong: Stocks flat at open

09:53 am

Go-Jek says will enter Singapore, Vietnam, Thailand, Philippines in next few months

Editor's Choice

Purchase this article as republication.

Purchase this article as keepsake.

1	Hyflux said to mull seeking court protection for creditor talks
2	Hyflux CEO Olivia Lum's letter to stakeholders
3	Hyflux seeks court protection to reorganise business, debt
4	SGX faces interim injunction on its new India equity derivative products; counter falls
5	Abuses pushed Malaysia's debt over RM1 trillion, says Mahathir

Companies & Markets

You are here

QT Vascular gets FDA nod for balloon catheter

Can Hyflux get it right this time?

House of Tan Yeok Nee back on the market

Noble saga offers lessons for Singapore capital market

Must Read

Singapore GDP up 4.4% in Q1, full-year growth forecast at 2.5-3.5%

Singapore manufacturing continues to drive growth in Q1; services catching up

Singapore non-oil exports up 1.1% in Q1; full-year forecast maintained at 1-3% growth

Trading suspension of Hyflux perps leaves investors out on a limb

You are here

QT Vascular gets FDA nod for balloon catheter

Market voices on:

Sign up for BT Newsletters

Editor's Choice

Most Read

Must Read